ライフサイエンスコーパス: biopsy

1 er prognosis offering a non-invasive "liquid biopsy".

2 erpes zoster antigen was not detected in any biopsy.

3 , we found a high rate of rejection (53%) on biopsy.

4 0%, respectively, were found to have HSIL on biopsy.

5 alterations by 40% with respect to a single biopsy.

6 icted to reduce harms from unnecessary liver biopsy.

7 -positive testing and the frequency of liver biopsy.

8 338 (31.9%) patients had no honeycombing or biopsy.

9 and IPCA, and number of nevi identified for biopsy.

10 rameters, abdomino-pelvic CT and a CT-guided biopsy.

11 icting aggressive prostate cancer at initial biopsy.

12 ic response, but generally requires invasive biopsy.

13 er; oral glucose tolerance test; and a liver biopsy.

14 imals and potentially in para-clinical human biopsy.

15 uidance, and (c) in-gantry MR imaging-guided biopsy.

16 needle core biopsy compared with excisional biopsy.

17 rmed to assess the presence of RNS in kidney biopsies.

18 this phenotype in PDX and in patient-derived biopsies.

19 ation of immune cells in entire human kidney biopsies.

20 progression from steatosis to NASH in liver biopsies.

21 used as biomarkers and a substitute for skin biopsies.

22 and often requires invasive tests and tissue biopsies.

23 with preadipocytes isolated from VAT and SAT biopsies.

24 able formalin-fixed paraffin-embedded (FFPE) biopsies.

25 rkers that will eliminate the need for scalp biopsies.

26 by immunohistochemistry (IHC) in 763 tissue biopsies.

27 Five years after biopsy, 0.0% (95% CI, 0.0-14.8) of persons with no/mild

28 Within 5 years of biopsy, 1.7% (95% confidence interval [CI]: 0.4-6.8) of

29 irculating cell free [cf); all patients] and biopsies [160 mg/day and expansion]) was sequenced.

30 ith those with ADH diagnosed via core needle biopsy (5%; 95% CI, 2.2%-8.9%).

31 s (43 males and 19 females; mean [SD] age at biopsy, 61.6 [13.7] years), 89.9% (124 of 138) were posi

32 In biopsies, 8 of the top 30 CD16a-inducible transcripts we

33 more likely to be diagnostic than ENB-guided biopsy (86.0% [129 of 150] vs 66.0% [99 of 150], respect

34 the PLA into their decision as to whether to biopsy a pigmented lesion suggestive of melanoma, dermat

35 On lesional biopsy, a lichenoid infiltrate was observed in the under

36 .7% female) who underwent MRE, TE, and liver biopsy analysis (using the histologic scoring system for

37 t may increase the number of early melanomas biopsied and reduce the number of benign lesions biopsie

38 uniform feature in a total of 21 sural nerve biopsies and 'onion bulb' formations and/or thin myelin

39 Adjacent microbiota were isolated from biopsies and analyzed by 16S gene sequencing.

40 Muscle biopsies and blood samples were collected to assess musc

41 METHODS AND Endomyocardial biopsies and blood samples were obtained from patients w

42 hometry analyses were performed on all other biopsies and cases were carefully reviewed in a blinded

43 tions for joint spine and tendon, aspiration biopsies and dermal fillers (DF).

44 The transcriptome derived from bronchial biopsies and epithelial brushings of 107 subjects with m

45 opsy cohorts had a gastroscopy with duodenal biopsies and quantitative histology within 2 weeks witho

46 Colonic biopsies and resected tissue from patients with IBD (n =

47 Although biopsies and tumor resection are prognostically benefici

48 agnosed through histology from chorioretinal biopsy and another case associated with a novel ARAF mut

49 lowed potentially by dermoscopic analysis, a biopsy and histopathological examination.

50 pendently associated with larger nephrons on biopsy and more glomerulosclerosis and arteriosclerosis

51 ndermined by harms from unnecessary prostate biopsy and overdiagnosis of indolent disease.

52 h biopsy-confirmed celiac disease, follow-up biopsies, and measurement of serum antibodies on a GFD,

53 ree (68.1%) patients had honeycombing and/or biopsy, and 338 (31.9%) patients had no honeycombing or

54 r diseases, diagnostics using in vivo liquid biopsy, and drug delivery methods.

55 x (>25 vs 18.5-25), history of benign breast biopsy, and nulliparity or age at first birth (>/=30 yea

56 lone and for considering transbronchial lung biopsy as a diagnostic tool.

57 GS or diffuse mesangial sclerosis on initial biopsy as well as age, serum albumin concentration, and

58 that histologic findings on postreperfusion biopsy associate with outcomes after deceased donor but

59 Fecal and rectal biopsy-associated microbiota composition was analyzed by

60 r status assessment, particularly in view of biopsy-associated sampling errors and heterogeneous rece

61 related with morphologic findings from index biopsies at the time of initial PVN diagnosis.

62 a median of 49 months; 74% underwent initial biopsy at a referring institution.

63 ho (a) had not previously undergone prostate biopsy, (b) had prior negative biopsy findings with incr

64 independently associated with lower risk of biopsy-based Gleason score upgrade (hazard ratio per 1-y

65 examine the association of age with risk of biopsy-based Gleason score upgrade during AS.

66 cers are clinically diagnosed using invasive biopsy-based tests, which are performed only in centrali

67 ation of diagnostics readout of other liquid biopsy biosources.

68 sease to avoid gluten challenge and duodenal biopsy, but requires validation in a larger study.

69 agnosis were obtained via minimally invasive biopsy, but the results were negative.

70 TRUS-biopsy can cause side-effects including bleeding, pain,

71 Transvitreal and transscleral needle biopsy can result in complications including vitreous he

72 DNA obtained from 20 fresh OSCC biopsies (cases) and 20 deep-epithelium swabs (matched c

73 dpoint is a reduced number of eosinophils in biopsies, changes in symptoms and endoscopic features ar

74 tion of EVs which can be employed for liquid biopsy clinically as well as for the study of intercellu

75 ) of three Nexvax2 150 mug recipients in the biopsy cohort.

76 n challenge, which had a fixed sequence, and biopsy cohorts had a gastroscopy with duodenal biopsies

77 women whose ADH was diagnosed by needle core biopsy compared with excisional biopsy.

78 tations that were undetectable in the tissue biopsy, conceivably because, due to spatial tumor hetero

79 In a meta-analysis of patients with biopsy-confirmed celiac disease undergoing follow-up bio

80 usion criteria were studies of subjects with biopsy-confirmed celiac disease, follow-up biopsies, and

81 ated, MSI or MMRD determined by preoperative biopsies could be used to select patients for perioperat

82 71% of biopsies demonstrated epineurial perivascular inflammati

83 Skin biopsy-derived RNAs from 14 early systemic sclerosis pat

84 e with related end points, including overall biopsy-determined progression, definitive treatment, and

85 sitive or negative direct immunofluorescence biopsies (DIF) in patients with clinically typical ocula

86 a higher density of nerve fibers relative to biopsies during virological and clinical quiescence.

87 iRNA at clinically indicated and/or protocol biopsy events (n = 130).

88 on culture approaches, outgrowth from limbal biopsy explants and isolated cell seeded in low calcium

89 3 ng/mL after negative transrectal US-guided biopsy findings underwent state-of-the-art, full multipa

90 Demographic and clinical characteristics and biopsy findings were correlated with the single-nephron

91 gone prostate biopsy, (b) had prior negative biopsy findings with increased prostate-specific antigen

92 Magnetic resonance images and core biopsy findings.

93 tive transrectal ultrasonography (US)-guided biopsy findings; to determine the significant cancer det

94 A biopsy followed a cortical tangential approach if the ne

95 HSIL was found in 26% and 18% of anal biopsies following initial and secondary screening, resp

96 Biopsies for histopathology were targeted to the IP, col

97 Six patients on therapy underwent a liver biopsy for flow cytometric analysis.

98 analyzed miRNA expression in diagnostic skin biopsies from 154 Danish patients with early-stage MF.

99 itzerland (validation cohort 1) and in liver biopsies from 20 patients (9 received corticosteroid tre

100 d the spatial heterogeneity of multiregional biopsies from 35 patients, using a combination of transc

101 Findings were validated using liver biopsies from 48 consecutive patients with severe AH tre

102 positional and mechanical properties of bone biopsies from bisphosphonate-treated patients with AFFs

103 , five also associate with renal fibrosis in biopsies from CKD patients and show concordant DNA methy

104 y IL-17-related cytokines in nasal/bronchial biopsies from controls and mild asthmatics (MAs) to seve

105 SGLT2 mRNA and protein is increased in renal biopsies from human subjects with diabetic nephropathy.

106 , some experts recommend to routinely obtain biopsies from IP for histopathology.

107 immunofluorescence result than patients with biopsies from other sites.

108 miR-223 was increased in intestinal biopsies from patients with active IBD and in preclinica

109 s associated with rapid DKD progression, and biopsies from patients with DKD showed increased mitocho

110 o analyze tumor heterogeneity among multiple biopsies from the same patient, it helps to reveal the m

111 Whole skin biopsies from the same subjects were evaluated concurren

112 using meta-analysis of over six FSHD muscle biopsy gene expression studies, and validated by RNA-seq

113 Women with ADH diagnosed on excisional biopsy had a slightly higher risk (6.7%; 95% CI, 3.0%-12

114 inary testing algorithm to restrict prostate biopsy has greater potential cost-benefit in younger men

115 ift was also observed in human failing heart biopsies in comparison with nonfailing controls.

116 ncreased in the ASM bundles in endobronchial biopsies in severe asthmatics.

117 ve at an early diagnosis and also to obviate biopsy in cases with classical imaging findings.

118 SSO) guideline for sentinel lymph node (SLN) biopsy in melanoma.

119 he "screening blood sample" used to guide BM biopsy in suspected SM to the outcome of the subsequent

120 test replacement strategy (to replace liver biopsy) in making key decisions in the management of pat

121 roportion of globally sclerotic glomeruli on biopsy increased by only 15%.

122 ical studies previously obtained on the core biopsy indicated that the tumor was positive for estroge

123 omission of cancer surgery when image-guided biopsy indicates a breast pCR.

124 gesting that acute treatment of small tumour biopsies is worthy of further exploration as a pre-clini

125 testing has high diagnostic reliability and biopsy is a confirmatory procedure.

126 usion Image-guided transthoracic core needle biopsy is an effective method for obtaining tissue for P

127 Conclusion In-bore 3-T MR-guided biopsy is safe and effective for prostate cancer diagnos

128 This "liquid biopsy" is quicker and more easily repeated than tissue

129 of intrahepatic T cells isolated from liver biopsy led to the targeted treatment with anti-tumor nec

130 2 lesions], WHO III: 17, WHO IV: 13, without biopsy low-grade: 1, high-grade: 1) were investigated wi

131 paired pretreatment and posttreatment liver biopsies, magnetic resonance elastography, magnetic reso

132 g of significant intratumoral heterogeneity, biopsies may not be representative of the entirety of th

133 In asthmatic bronchial biopsies, mCD48 was expressed predominantly by eosinophi

134 er a 10-year period that had undergone liver biopsies (n = 363) were scored for the presence of bile

135 We discovered that skin biopsies obtained during asymptomatic human HSV-2 reacti

136 stry in cryostat sections of bronchial/nasal biopsies obtained from 33 SAs (21 frequent exacerbators

137 genetic markers between physically isolated biopsies of a single tumor poses major barriers to the i

138 lminant hepatitis 1 HCV strain as well as in biopsies of chronic HCV patients.

139 c-Kit(+) hCPCs were isolated from cardiac biopsies of multiple HF patients undergoing left ventric

140 icle, we show that the expression of IL19 in biopsies of patients with active ulcerative colitis was

141 e gene expression profiles from whole kidney biopsies of patients with SLE.

142 Here, we report upregulation of CBS in human biopsies of precancerous adenomatous polyps and show tha

143 tive metabolomics in a mouse model and human biopsies of prostate cancer, we identify alterations in

144 own from lesional (PP) and non-lesional (PN) biopsies of psoriasis patients and control subjects (NN)

145 y transvitrector port fine-needle aspiration biopsy of the tumor immediately before implantation of a

146 onfirmed celiac disease undergoing follow-up biopsy on a GFD, we found that tests for serum tTG IgA a

147 Tumor biopsies or malignant ascites were collected from patien

148 to a previous percutaneous or bronchoscopic biopsy or previous surgical biopsy or resection.

149 t temozolomide is the standard of care after biopsy or resection of newly diagnosed glioblastoma in p

150 or bronchoscopic biopsy or previous surgical biopsy or resection.

151 ogical analysis of the tumour specimen after biopsy or surgery, and we classified patients by tumour

152 ography or magnetic resonance imaging scans, biopsies, or other procedures performed for false-positi

153 ed with cardiac fibrosis on left ventricular biopsy (P=0.63; P<0.01).

154 sted against the FDA-approved SP263 clone on biopsied patient tissues.

155 RATIONALE: In the absence of a surgical lung biopsy, patients diagnosed with idiopathic pulmonary fib

156 (PPV2), 27.5% (95% CI: 27.1%, 27.9%); PPV of biopsies performed (PPV3), 30.4% (95% CI: 29.9%, 30.9%);

157 were reviewed in 431 CT-guided medical renal biopsies performed between July 2007 and September 2015.

158 nd measurement of serum antibodies on a GFD, biopsy performed on subjects regardless of symptoms, or

159 ite (89)Zr-labeled radiotracer PET/CT-guided biopsy performed without reinjection.

160 he cancer positive group (PCa+) comprised 35 biopsy positive (Bx+) subjects from three institutions (

161 d 6 patients with penile cancer during an SN biopsy procedure using indocyanine green-(99m)Tc-nanocol

162 sttransplant DSA monitoring and surveillance biopsy program for dnDSA since 2014.

163 Among 237 patients with initial biopsy-proved N1 disease, 69 of 77 (89.6%) with and 68 o

164 Cumulative rates of biopsy-proven acute rejection (BPAR) from first randomiz

165 domized clinical trial open to patients with biopsy-proven carcinoma of the esophagus.

166 All patients had HCV infection and biopsy-proven cirrhosis, were Child-Pugh class A, and ha

167 against 21 board-certified dermatologists on biopsy-proven clinical images with two critical binary c

168 ed YAP protein in glomeruli of patients with biopsy-proven focal segmental glomerulosclerosis (FSGS).

169 ging Reporting and Data System category 5 or biopsy-proven HCC and who were undergoing TAE were enrol

170 , or 5 masses assessed at diagnostic US with biopsy-proven histologic findings and BI-RADS 3 masses s

171 lyzed serum metabolomes of 535 patients with biopsy-proven NAFLD (353 with simple steatosis and 182 w

172 a well-characterized cohort of patients with biopsy-proven NAFLD, this study demonstrates that hepati

173 Patients with biopsy-proven PMN and nephrotic syndrome after 6 months

174 men; mean age, 71.9 years +/- 10.9) with 217 biopsy-proven renal cell carcinoma tumors treated with t

175 A consecutive series of 55 patients with biopsy-proven SUSCC without bone invasion treated by wid

176 th inflammatory cell count on endomyocardial biopsy (r=0.56; P<0.05).

177 ated with higher abnormal interpretation and biopsy rates and lower specificity, with no difference i

178 12.7%); positive predictive value (PPV) of a biopsy recommendation (PPV2), 27.5% (95% CI: 27.1%, 27.9

179 ion rate (CDR), positive predictive value of biopsy recommendation (PPV2), sensitivity, and specifici

180 us high BPE groups at diagnostic MR imaging, biopsy recommendation rate was 325 of 1443 versus 195 of

181 me of interest was presence of melanoma in a biopsied regional LN.

182 e sample for diagnostic testing and rates of biopsy-related complications were assessed.

183 ace, digital rectal examination results, and biopsy results before MR imaging.

184 ied immunosuppression (IIS), 1155 had kidney biopsy results, and 212 had an established genetic diagn

185 All imaging observers were blinded to the biopsy results, and all hepatopathologists were blinded

186 ic imaging findings were concordant with the biopsy results.

187 Biopsies revealed elevated renal ENDATs in most particip

188 Site-directed biopsies revealed enriched MIF and VEGF at the enhancing

189 ticle we show high production of IL-1beta in biopsy samples and Leishmania antigen-stimulated periphe

190 Studying 213 archival biopsy samples from 17 patients, we used somatic variant

191 We obtained liver biopsy samples from 69 patients with chronic HCV infecti

192 gulated in vitiligo cell line PIG3V and skin biopsy samples from vitiligo patients, whereas its predi

193 tients without GC (AG/IM GC-) and in control biopsy samples of non-transformed gastric mucosa (Contro

194 compared with histopathology of core needle biopsy samples or with ultrasound follow-up data of the

195 Eleven human liver biopsy samples underwent MPO-Gd-enhanced MR imaging ex v

196 IL28A, IL28RA, and other related cytokines; biopsy samples were also analyzed by immunofluorescence

197 Repeated blood and muscle biopsy samples were collected to assess whole-body leuci

198 Thanks to clinically accessible biopsy samples, high-quality molecular data for psoriasi

199 mRNA expression in chronic HCV patient liver biopsy samples.

200 epatitis (NASH) mouse models and human liver biopsy samples.

201 he consequences of more versus less frequent biopsies seem to be similar across cohorts.

202 melanoma, dermatologists improved their mean biopsy sensitivity from 95.0% to 98.6% (P = .01); specif

203 C4d+/AVB+ microvesicles correlated with AMR biopsy severity.

204 Tumor biopsies showed decreases in cell-signaling pathways (Bc

205 ones that were anatomically distant from the biopsy site.

206 The biopsy sites were bone (n = 7), pleura (n = 3), lymph no

207 ed at the margins of EMPD, close to previous biopsy sites.

208 recommendations on the use of sentinel node biopsy (SNB) for patients with early-stage breast cancer

209 The benefit of adding sentinel node biopsy (SNB) to extended pelvic lymph node dissection (e

210 , we obtained and analyzed the sections of a biopsy specimen of the cortex to determine the density o

211 The biopsy specimen revealed adenocarcinoma with no actionab

212 After histologic analysis of the bone marrow biopsy specimen, diagnosis of Waldenstrom macroglobuline

213 Studying the patient's renal biopsy specimen, we ascertained that obstructive tubular

214 Western blotting) and in normal and AE skin biopsy specimens (immunofluorescence).

215 ere compared to histopathology findings from biopsy specimens and radiology reports on MR images to e

216 ased IL-36alpha expression detected in renal biopsy specimens and urine samples from patients with re

217 amma isoforms was observed in HIV-related KS biopsy specimens compared with non-HIV-related KS and NS

218 on in the podocytes and glomeruli from human biopsy specimens correlated with glucocorticoid responsi

219 Finally, immunostaining in kidney biopsy specimens demonstrated overexpression of ShcA in

220 Human colonic biopsy specimens exposed to G. duodenalis were depleted

221 proximal tubules from 98 human needle kidney biopsy specimens for microRNA expression analysis using

222 The NanoString technology used in 38 cSCC biopsy specimens from 24 patients with cSCC (19 men and

223 and a ligand (PD-L2) was assessed in 38 cSCC biopsy specimens from 24 patients with cSCC.

224 in 1-mm basal layers was determined in skin biopsy specimens from all lesions stained with hematoxyl

225 Biopsy specimens from both periods were diagnosed by the

226 evels of moesin were also observed in muscle biopsy specimens from DMD, Ullrich CMD, and merosin-defi

227 metatranscriptomic RNA sequencing of stomach biopsy specimens from individuals with different H. pylo

228 ical value of a granzyme B imaging paradigm, biopsy specimens from melanoma patients on checkpoint in

229 , to reduce mucosal morphometric measures in biopsy specimens from patients with celiac disease.

230 This case-control study obtained punch biopsy specimens from patients with HS (lesional and non

231 nd integrin-beta3 were highly colocalized in biopsy specimens from patients with inflammatory GN.

232 ences from viruses isolated from primary NPC biopsy specimens in this region, revealing whole-genome

233 e variation in EBV isolated from primary NPC biopsy specimens obtained from the Hunan Province.

234 RNA-122 (miR-122) is down-regulated in liver biopsy specimens of patients with ALF and in acetaminoph

235 Intestinal biopsy specimens of patients with CD were scored accordi

236 l cell suspensions and ILC3s sorted from gut biopsy specimens of patients with IBD were also analyzed

237 n detection of Marsh 2 or greater lesions in biopsy specimens or persistent high levels of tTGA.

238 Biopsy specimens were analyzed at the Department of Micr

239 Skin biopsy specimens were collected after intradermal allerg

240 A total of 15110 skin biopsy specimens were included.

241 derwent standard colonoscopies, during which biopsy specimens were obtained from the ileum.

242 Here, we demonstrate, using patient biopsy specimens, that HD5 is also expressed as an activ

243 ately 4.5-fold in H. pylori-infected gastric biopsy specimens.

244 Ls) from RCDII as well as non-RCDII duodenal biopsy specimens.

245 PM8); and nerve growth factor (NGF) in nasal biopsy specimens.

246 in H. pylori-infected and uninfected gastric biopsy specimens.

247 The following three MR imaging-guided biopsy strategies were further evaluated in each MR imag

248 ed, and 101 (91.8%) were performed as repeat biopsies subsequent to a previous percutaneous or bronch

249 rom 174 patients with cHL, including 71 with biopsies taken at both primary diagnosis and relapse, to

250 on/diversity with new single-cell and liquid biopsy technologies.

251 ns (HRLs) diagnosed with image-guided needle biopsy that require surgical excision to be distinguishe

252 retro-orbital puncture after enucleation and biopsied the frontal lobes and optic nerves of a macaque

253 sied and reduce the number of benign lesions biopsied, thereby improving patient outcomes and reducin

254 ason score, derived from individual prostate biopsy tissue cores.

255 ent, the volunteers underwent adipose tissue biopsies to measure the total (CD68(+)), pro- (CD14(+) =

256 Here we used HCV-infected cells and liver biopsies to study how HCV modulates the glutaminolysis p

257 as accurate as genotyping of the diagnostic biopsy to detect clonally represented somatic tumor muta

258 Fabry disease) can be evaluated with a skin biopsy to visualize pathologically decreased densities o

259 HLA donor-specific antibodies at the time of biopsy, together with systematic gene expression assessm

260 (FISH)-supplemented immunohistochemistry of biopsied tumor tissue.

261 ic acid yields in CT-guided lung core needle biopsies used for genomic analysis, there should be a pr

262 We also assessed whether liver biopsy versus follow-up with the same versus alternative

263 ombing on HRCT and/or confirmation of UIP by biopsy versus patients without either, using pooled data

264 for physician and practice characteristics, biopsy volume decreased by 28.7% following 2012 (paramet

265 bability of having non-dysplastic endoscopic biopsies was 13% (5-27), whereas the probability of havi

266 ight to crypt depth ratio in distal duodenal biopsies was not significantly different between those w

267 ductal hyperplasia diagnosed via excisional biopsy was associated with an adjusted hazard ratio (HR)

268 For some patients, tumour biopsy was done before lorlatinib treatment to identify

269 Repeat transperineal biopsy was performed at 6 and 24 months.

270 In-bore 3-T MR-guided prostate biopsy was performed in 134 targets in 106 men who (a) h

271 Skin biopsy was performed in all eight affected members and r

272 copy techniques, applied to routine duodenum biopsies, we were able to record neuronal Ca(2+) respons

273 Biopsies were analysed for mRNA levels of selected genes

274 Biopsies were collected from the gluteus medius and tric

275 Asthmatic bronchial biopsies were immunostained for CD48.

276 Biopsies were incubated with gluten digested with chymot

277 Biopsies were independently scored by six liver patholog

278 Patients who had conjunctival biopsies were more likely to have a negative direct immu

279 Left ventricular biopsies were obtained from 5 donors and 26 patients wit

280 Results A total of 110 intrathoracic biopsies were performed, and 101 (91.8%) were performed

281 Muscle biopsies were taken from eight Trained, Lean sedentary,

282 Six standard gastric biopsies were taken.

283 Human intestinal biopsies were used in clinical data analysis.

284 hter's transformation and cases confirmed by biopsy were excluded.

285 ediatric patients scheduled to undergo liver biopsy were studied with an ultrasonography-based SWE sy

286 Adjacent sections of the same biopsy were then examined by immunohistochemistry, using

287 t that the AH can serve as a surrogate tumor biopsy when Rb tumor tissue is not available.

288 ients with an SRM should be considered for a biopsy when the results may alter management.

289 ents turned C4d-negative in 5-week follow-up biopsies, while another 2 recipients showed a substantia

290 ll-selective transcripts CD160 and XCL1 with biopsies with AMR provides evidence for NK cell CD16a ac

291 Biopsies with de novo non-HLA autoantibodies revealed a

292 mbining expression studies in human clinical biopsies with functional analyses in cell lines and mous

293 resented in >20% of the alleles of the tumor biopsy with >90% sensitivity and approximately 100% spec

294 r evaluated in each MR imaging category: (a) biopsy with cognitive guidance, (b) biopsy with MR imagi

295 ory: (a) biopsy with cognitive guidance, (b) biopsy with MR imaging/US fusion guidance, and (c) in-ga

296 ned as having any of the following: a kidney biopsy with PV associated nephropathy, any urine cytolog

297 of 3.0 (95% CI, 2-4.5) and, via core needle biopsy, with an adjusted HR of 2.2 (95% CI, 1.5-3.4).

298 2014 and February 2017 who underwent kidney biopsy within 60 days of detection of dnDSA.

299 Forty patients who had had a liver biopsy within the previous month were recruited.

300 quicker and more easily repeated than tissue biopsy, yields real-time information about the cancer, a